PHARMAKON ADVISORS
Pharmakon Advisors is a New York-based investment company that offers financing solutions to commercial stage, biotechnology companies.
PHARMAKON ADVISORS
Status:
Active
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-08 | UroGen Pharma | Pharmakon Advisors investment in Post-IPO Debt - UroGen Pharma | 100 M USD |
| 2022-01-07 | Coherus Biosciences | Pharmakon Advisors investment in Post-IPO Debt - Coherus Biosciences | 100 M USD |
| 2021-12-14 | Evolus | Pharmakon Advisors investment in Post-IPO Debt - Evolus | 125 M USD |
| 2020-12-08 | BRAINBox Solutions | Pharmakon Advisors investment in Series A - BRAINBox Solutions | 23 M USD |
| 2020-09-12 | OptiNose | Pharmakon Advisors investment in Post-IPO Debt - OptiNose | 150 M USD |
| 2019-12-13 | Sarepta Therapeutics | Pharmakon Advisors investment in Post-IPO Debt - Sarepta Therapeutics | 250 M USD |
| 2019-11-12 | Akebia Therapeutics | Pharmakon Advisors investment in Post-IPO Debt - Akebia Therapeutics | 100 M USD |
| 2016-01-05 | Halozyme Therapeutics | Pharmakon Advisors investment in Post-IPO Debt - Halozyme Therapeutics | 150 M USD |
| 2015-03-13 | Assertio | Pharmakon Advisors investment in Post-IPO Debt - Assertio | 575 M USD |
| 2014-07-28 | PaxVax | Pharmakon Advisors investment in Debt Financing - PaxVax | 50 M USD |